Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.

By John C. Davis, D. van der Heijde, J. Braun, M. Dougados, J. Cush, D. Clegg, A. Kivitz, R. Fleischmann, R. Inman, W. Tsuji. Arthritis & Rheumatism, 2003

760 citations recorded by the source corpus.

Subfields: Pathology and Forensic Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/9d221d6ca30a53b47e7987aac4b20f74a5e8412a